Clinical Edge Journal Scan

Depression and risk for death in RA: Is there a link?


 

Key clinical point: Depression significantly predicted death in patients with incident rheumatoid arthritis (RA), but with a strength similar to that in matched comparator individuals without RA.

Major finding: The risk for all-cause mortality was >3-fold higher (adjusted hazard rate ratio [aHRR] 3.15; 95% CI 2.62-3.79) in patients with RA with vs without depression, with the risk being higher among patients age < 55 years compared with other age groups (aHRR 8.13; 95% CI 3.89-17.02). In addition, depression predicted all-cause mortality with similar strength in comparator individuals without RA (aHRR 3.77; 95% CI 3.48-4.08).

Study details: This study included 11,071 patients with incident RA and 55,355 matched comparator individuals without RA from the general population.

Disclosures: This study was supported by the Danish Rheumatism Association. The authors declared no conflicts of interest.

Source: Pedersen JK et al. Mortality in patients with incident rheumatoid arthritis and depression: A Danish cohort study of 11,071 patients and 55,355 comparators. Rheumatology (Oxford). 2023 (May 30). doi: 10.1093/rheumatology/kead259

Recommended Reading

High-intensity interval training has sustainable effects in patients with inflammatory arthritis
MDedge Rheumatology
RA and demyelinating disease: No consistent link to TNFi
MDedge Rheumatology
AI efforts make strides in predicting progression to RA
MDedge Rheumatology
After Yusimry’s steep discount, little clarity on future adalimumab biosimilar pricing
MDedge Rheumatology
Peresolimab shows efficacy as a new treatment approach for moderate-to-severe RA
MDedge Rheumatology
Antimalarials improve safety and persistence of bDMARD or JAKi treatment in RA
MDedge Rheumatology
Frailty raises risk for methotrexate discontinuation due to adverse events in RA
MDedge Rheumatology
Higher risk for herpes zoster with tofacitinib vs TNFi in RA
MDedge Rheumatology
Hydroxychloroquine confers dose-dependent survival benefits in elderly-onset RA
MDedge Rheumatology
Perioperative JAKi use seems safe in RA patients undergoing orthopedic procedure
MDedge Rheumatology